The involvement of Rho-associated kinases in agonist-dependent contractions of human maternal and placental arteries at term gestation

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 3, 2005, Pages 815-824

  Wareing, Mark ^a   O'Hara, Maureen ^a   Seghier, Fella ^a   Baker, Philip N ^a   Taggart, Michael J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Human arteries; Pregnancy; Rho kinase

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALCIUM ION; CALYCULIN A; RHO KINASE;

ADULT; ARTERY; ARTICLE; CELL PERMEABILIZATION; CESAREAN SECTION; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; HUMAN; MUSCLE CONTRACTION; MYOMETRIUM; PLACENTA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREGNANCY; PRIORITY JOURNAL; REDUCTION; WESTERN BLOTTING;

AMIDES; ARTERIES; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE RELAXANTS, CENTRAL; MUSCLE, SMOOTH, VASCULAR; MYOMETRIUM; OMENTUM; OXAZOLES; PHOSPHOPROTEIN PHOSPHATASE; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; VASOCONSTRICTION;

EID: 24344460539     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.02.076     Document Type: Article

References (28)

1. G. D'Angelo, and G. Osol Regional variation in resistance artery diameter responses to alpha-adrenergic stimulation during pregnancy Am J Physiol 264 1993 H78 H85
2. M. Hermsteiner, D.R. Zoltan, and W. Kunzel The vasoconstrictor response of uterine and mesenteric resistance arteries is differentially altered in the course of pregnancy Eur J Obstet Gynaecol Reprod Biol 100 2001 29 35
3. B.J. Wilson, M.S. Watson, G.J. Prescott, S. Sunderland, D.M. Campbell, and P. Hannaford Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study BMJ 326 2003 845 851
4. B. Kestenbaum, S.L. Seliger, T.R. Easterling, D.L. Gillen, C.W. Critchlow, and C.O. Stehman-Breen Cardiovascular and thromboembolic events following hypertensive pregnancy Am J Kidney Dis 42 2003 982 989
5. C. Aalkjaer, H. Danielsen, P. Johannesen, E.B. Pedersen, A. Rasmussen, and M.J. Mulvany Abnormal vascular function and morphology in pre-eclampsia: a study of isolated resistance vessels Clin Sci (Lond) 69 1985 477 482
6. Pascoal IF, Lindheimer MD, Nalbantian-Brandt C, Umans JG. Pre-eclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest 1998;101:464-70.
7. 2+, crossbridge phosphorylation and contraction Ann Rev Physiol 51 1989 285 298
8. K. Sward, M. Mita, D.P. Wilson, J.T. Deng, M. Susnjar, and M.P. Walsh The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction Curr Hypertens Rep 5 2003 66 72
9. 2+-sensitivity of smooth muscle and nonmuscle myosin. II. Modulated by g-proteins, kinases and myosin phosphatase Physiol Rev 83 2003 1325 1358
10. K. Kimura, M. Ito, M. Amano, K. Chihara, Y. Fukata, and M. Nakafuku Regulation of myosin phosphatase by Rho and Rho-associated kinase Science 273 1996 245 248
11. K. Ichikawa, M. Ito, and D.J. Hartshorne Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity J Biol Chem 271 1996 4733 4740
12. 2+-sensitisation of myosin phosphorylation and force in guinea-pig ileum J Physiol 522 2000 33 49
13. 2+-sensitisation in rabbit smooth muscle J Physiol 546 2003 879 889
14. 2+-sensitisation of smooth muscle contraction through myosin light chain phosphorylation J Biol Chem 266 1991 1708 1715
15. M. Ueheta, T. Ishizaki, H. Satoh, T. Ono, T. Kawahara, and T. Morishita Calcium sensitisation of smooth muscle mediated by a Rho-associated protein kinase in hypertension Nature 389 1998 990 994
16. 2+-sensitisation of smooth muscle FEBS Lett 440 1998 183 187
17. T. Ishizaki, M. Ueheta, I. Tamechika, J. Keel, K. Nonomura, and M. Maekawa Pharmacological properties of Y27632, a specific inhibitor of rho-associated kinases Mol Pharmacol 57 2000 976 983
18. H. Shimokawa, K. Morishige, K. Miyata, T. Kandabashi, Y. Eto, and I. Ikegaki Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo Cardiovasc Res 51 2001 169 177
19. K. Morishige, H. Shimokawa, Y. Eto, T. Kandabashi, K. Miyata, and Y. Matsumoto Adenovirus-mediated transfer of dominant-negative Rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo Arterioscler Thromb Vasc Biol 21 2001 548 554
20. T. Kandabashi, H. Shimokawa, Y. Mukai, T. Matoba, I. Kunihiro, and K. Morikawa Involvement of rho-kinase in agonist-induced contractions of arteriosclerotic human arteries Arterioscler Thromb Vasc Biol 22 2002 243 248
21. T.J.P. Batchelor, J.R. Sadaba, A. Ishola, P. Pacaud, C.M. Munsch, and D.J. Beech Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery Brit J Pharmacol 132 2001 302 308
22. 2+ handling of human small arteries Am J Physiol 279 2000 H1228-H38
23. S. Kupittayanant, T. Burdyga, and S. Wray The effects of inhibiting Rho-associated kinase with Y-27632 on force and intracellular calcium in human myometrium Pflugers Arch 443 2001 112 114
24. C.J. Moran, A.M. Friel, T.J. Smith, M. Cairns, and J.J. Morrison Expression and modulation of Rho kinase in human pregnant myometrium Mol Human Reprod 8 2002 196 200
25. N.A. Woodcock, C.W. Taylor, and S. Thornton Effect of an oxytocin receptor antagonist and rho kinase inhibitor on the [Ca++]i sensitivity of human myometrium Am J Obstet Gynecol 190 2004 222 228
26. M. Wareing, M. Bhatti, M. O'Hara, L. Kenny, A.Y. Warren, and M.J. Taggart Vasoactive effects of neurokinin B on human blood vessels Am J Obstet Gynecol 188 2003 196 202
27. K. Horiutu Mechanism of contracture on cooling of caffeine-treated frog skeletal muscle fibres J Physiol 398 1988 131 148
28. M.C. Gong, P. Cohen, T. Kitazawa, M. Ikebe, M. Masuo, and A.P. Somlyo Myosin light chain phosphatase activities an the effects of phosphatase inhibitors in tonic and phasic smooth muscle J Biol Chem 267 1992 14662 14668